320 related articles for article (PubMed ID: 7035044)
1. Renal tubular dysfunction as a complication of gold therapy in patients with rheumatoid arthritis.
Iesato K; Mori Y; Ueda S; Wakashin Y; Wakashin M; Matsui N; Inoue S; Okuda K
Clin Nephrol; 1982 Jan; 17(1):46-52. PubMed ID: 7035044
[TBL] [Abstract][Full Text] [Related]
2. [Possible role of cellular immunity against tubular basement membrane antigen (TBM) in gold nephropathy in rheumatoid arthritis patients].
Wakashin Y; Ueda S; Yoshida H; Mori T; Mori Y; Iesato K; Ogawa M; Wakashin M
Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):657-67. PubMed ID: 1362229
[TBL] [Abstract][Full Text] [Related]
3. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
Billingsley LM; Stevens MB
Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
[TBL] [Abstract][Full Text] [Related]
4. [Tubular nephropathy in chronic polyarthritis].
Rautenstrauch H; Knoll E; Wisser H
Z Rheumatol; 1979; 38(7-8):252-6. PubMed ID: 506488
[TBL] [Abstract][Full Text] [Related]
5. Gold nephropathy: tissue analysis by X-ray fluorescent spectroscopy.
Viol GW; Minielly JA; Bistricki T
Arch Pathol Lab Med; 1977 Dec; 101(12):635-40. PubMed ID: 412488
[TBL] [Abstract][Full Text] [Related]
6. [Kidney tubular injury in the use of sodium aurothiomalate and its detection by determination of urinary beta-2-microglobulin].
Ulreich A; Rainer F; Sedlmayr DP; Leb G; Pfeiffer K
Wien Klin Wochenschr Suppl; 1984; 156():56-7. PubMed ID: 6442061
[No Abstract] [Full Text] [Related]
7. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
[TBL] [Abstract][Full Text] [Related]
8. Chronic interstitial nephritis associated with gold therapy.
Cramer CR; Hagler HK; Silva FG; Eigenbrodt EH; Meltzer JI; Pirani CL
Arch Pathol Lab Med; 1983 May; 107(5):258-63. PubMed ID: 6404236
[TBL] [Abstract][Full Text] [Related]
9. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of circulating anti-tubular basement membrane-antibody in renal diseases, and clinical observations.
Lindqvist B; Lundberg L; Wieslander J
Clin Nephrol; 1994 Apr; 41(4):199-204. PubMed ID: 8026111
[TBL] [Abstract][Full Text] [Related]
11. [Side effect of aurothiomalate in the treatment of rheumatoid arthritis, with reference to renal lesions].
Masuda M; Yoshino S; Okitsu K; Igarashi M; Hayashi Y
Ryumachi; 1974 Oct; 14(3):274-8. PubMed ID: 4450158
[No Abstract] [Full Text] [Related]
12. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
Stein HB; Ruedy J; Atkins CJ; Offer RC
J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
[TBL] [Abstract][Full Text] [Related]
13. Renal injury in patients with rheumatoid arthritis treated with gold.
Merle LJ; Reidenberg MM; Camacho MT; Jones BR; Drayer DE
Clin Pharmacol Ther; 1980 Aug; 28(2):216-22. PubMed ID: 6994990
[TBL] [Abstract][Full Text] [Related]
14. [Modifications in alpha 2 globulins, gamma globulins and in rheumatoid factor during gold salt therapy in rheumatoid arthritis].
Gropuzzo M; Masoch G; Gambari PF; Todesco S
Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2435-9. PubMed ID: 92320
[TBL] [Abstract][Full Text] [Related]
15. [Gold salts in the treatment of psoriatic arthritis].
Koó E; Seszták M
Orv Hetil; 1990 Jan; 131(4):179-81. PubMed ID: 2320370
[TBL] [Abstract][Full Text] [Related]
16. [Subclinical renal involvement in rheumatoid arthritis].
Geltner D; Alon A; Hoffstein R; Bar-Khayim Y
Harefuah; 1992 Oct; 123(7-8):255-8, 307, 306. PubMed ID: 1459500
[TBL] [Abstract][Full Text] [Related]
17. Experimental gold nephropathy in guinea pigs: detection of autoantibodies to renal tubular antigens.
Ueda S; Wakashin M; Wakashin Y; Yoshida H; Iesato K; Mori T; Mori Y; Akikusa B; Okuda K
Kidney Int; 1986 Feb; 29(2):539-48. PubMed ID: 3084839
[TBL] [Abstract][Full Text] [Related]
18. Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy.
Landewé RB; Dijkmans BA; van der Woude FJ; Breedveld FC; Mihatsch MJ; Bruijn JA
J Rheumatol; 1996 Jan; 23(1):61-4. PubMed ID: 8838509
[TBL] [Abstract][Full Text] [Related]
19. Renal tubular dysfunction in schizophrenic patients treated with antipsychotic drugs.
Tutor-Crespo MJ; Paz E; Hermida J; Tutor JC
Clin Lab; 2007; 53(7-8):433-8. PubMed ID: 17821947
[TBL] [Abstract][Full Text] [Related]
20. Gold nephropathy in rheumatoid arthritis and in juvenile chronic arthritis.
Rovenská E; Kapeller K; Rossmann P
Czech Med; 1979; 2(3):125-33. PubMed ID: 535499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
